Plasmodium falciparum ligand binding to erythrocytes induce alterations in deformability essential for invasion by Sisquella, Xavier et al.




Plasmodium falciparum ligand binding to
erythrocytes induce alterations in deformability
essential for invasion
Xavier Sisquella
The Walter and Eliza Hall Institute of Medial Research
Thomas Nebl
The Walter and Eliza Hall Institute of Medical Research
Jennifer K. Thompson
The Walter and Eliza Hall Institute of Medical Research
Lachlan Whitehead
The Walter and Eliza Hall Institute of Medical Research
Brian M. Malpede
Washington University School of Medicine in St. Louis
See next page for additional authors
Follow this and additional works at: https://digitalcommons.wustl.edu/open_access_pubs
This Open Access Publication is brought to you for free and open access by Digital Commons@Becker. It has been accepted for inclusion in Open
Access Publications by an authorized administrator of Digital Commons@Becker. For more information, please contact engeszer@wustl.edu.
Recommended Citation
Sisquella, Xavier; Nebl, Thomas; Thompson, Jennifer K.; Whitehead, Lachlan; Malpede, Brian M.; Salinas, Nichole D.; Rogers, Kelly;
Tolia, Niraj H.; Fleig, Andrea; O'Neill, Joseph; Tham, Wai-Hong; Horgen, F. David; and Cowman, Alan, ,"Plasmodium falciparum
ligand binding to erythrocytes induce alterations in deformability essential for invasion." Elife.6,e21083. 1-20. (2017).
https://digitalcommons.wustl.edu/open_access_pubs/5625
Authors
Xavier Sisquella, Thomas Nebl, Jennifer K. Thompson, Lachlan Whitehead, Brian M. Malpede, Nichole D.
Salinas, Kelly Rogers, Niraj H. Tolia, Andrea Fleig, Joseph O'Neill, Wai-Hong Tham, F. David Horgen, and
Alan Cowman




authors declare that no
competing interests exist.
Funding: See page 15
Received: 30 August 2016
Accepted: 09 February 2017
Published: 22 February 2017
Reviewing editor: Stephen C.
Harrison, Harvard Medical
School, United States
Copyright Sisquella et al. This
article is distributed under the
terms of the Creative Commons
Attribution License, which
permits unrestricted use and
redistribution provided that the
original author and source are
credited.
Plasmodium falciparum ligand binding to
erythrocytes induce alterations in
deformability essential for invasion
Xavier Sisquella1, Thomas Nebl1, Jennifer K Thompson1, Lachlan Whitehead1,
Brian M Malpede2,3, Nichole D Salinas2,3, Kelly Rogers1, Niraj H Tolia2,3,
Andrea Fleig4, Joseph O’Neill1, Wai-Hong Tham1,5, F David Horgen6,
Alan F Cowman1,5*
1The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia;
2Molecular Microbiology and Microbial Pathogenesis, Washington University School
of Medicine, St. Louis, United States; 3Biochemistry and Molecular Biophysics,
Washington University School of Medicine, St. Louis, United States; 4The Queen’s
Medical Center and John A. Burns School of Medicine, University of Hawaii,
Honolulu, United States; 5Department of Medical Biology, The University of
Melbourne, Parkville, Australia; 6Department of Natural Sciences, Hawaii Pacific
University, Kaneohe, United States
Abstract The most lethal form of malaria in humans is caused by Plasmodium falciparum. These
parasites invade erythrocytes, a complex process involving multiple ligand-receptor interactions.
The parasite makes initial contact with the erythrocyte followed by dramatic deformations linked to
the function of the Erythrocyte binding antigen family and P. falciparum reticulocyte binding-like
families. We show EBA-175 mediates substantial changes in the deformability of erythrocytes by
binding to glycophorin A and activating a phosphorylation cascade that includes erythrocyte
cytoskeletal proteins resulting in changes in the viscoelastic properties of the host cell. TRPM7
kinase inhibitors FTY720 and waixenicin A block the changes in the deformability of erythrocytes
and inhibit merozoite invasion by directly inhibiting the phosphorylation cascade. Therefore,
binding of P. falciparum parasites to the erythrocyte directly activate a signaling pathway through a
phosphorylation cascade and this alters the viscoelastic properties of the host membrane
conditioning it for successful invasion.
DOI: 10.7554/eLife.21083.001
Introduction
Malaria is a major global disease of humans and the most severe form is caused by Plasmodium falci-
parum. This protozoan parasite has a complex life cycle, however, the symptoms of malaria are
mediated by the asexual blood stage that is initiated by the entry of the merozoite form into the
host erythrocyte. During the initial steps of the invasion, the merozoite intermittently contacts the
erythrocyte until it attaches and initiates internalization. Attachment and internalization involve a
series of dramatic changes that include deformation of the erythrocyte (Figure 1A) and calcium
(Ca2+) influx after which a tight junction is formed and invasion mediated using force generated by
the parasite actomyosin motor (Weiss et al., 2015; Volz et al., 2016). The mechanical alterations of
the erythrocyte that occur during merozoite invasion have been described using video-microscopy
(Weiss et al., 2015; Gilson et al., 2009). Merozoite invasion involves the interaction of multiple par-
asite ligands with specific erythrocyte receptors that include merozoite surface proteins (MSPs)
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Figure 1. P. falciparum EBA-175 RII binding to GPA increases deformability of the erythrocyte. (A) Live imaging time frames showing a merozoite
deforming an erythrocyte. Scale bar 5 mm. (B) Atomic force microscopy (AFM) screen of the effect of P. falciparum invasion ligands on the erythrocyte
Young’s modulus (E). (C) Schematics showing EBA-175 and EBA-140 domain structure (top). The bottom panel is the AFM Young’s modulus of
erythrocytes treated with EBA-175 region II, region III-IV and EBA-175 RII in the presence of EBA-175 RII antibodies (EBA-175+Ab). (D) AFM Young’s
Figure 1 continued on next page
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(Hodder et al., 2012), erythrocyte binding antigens (EBAs) (Adams et al., 2001) and reticulocyte
binding-like homologs (PfRhs) (Rayner et al., 2000; Triglia et al., 2001; Hayton et al., 2008;
Baum et al., 2009), and the functional requirement of these during specific steps of the invasion has
been defined (Weiss et al., 2015; Volz et al., 2016). This includes binding of the merozoite surface
protein Duffy Binding-Like 1 and 2 (MSPDBL1 and 2) with unknown receptors (Hodder et al., 2010),
EBA-175 with glycophorin A (GPA) (Orlandi et al., 1992), EBA-140 (also known as BAEBL) with gly-
cophorin C (GPC) (Maier et al., 2003), PfRh4 with Complement Receptor 1 (CR1) (Tham et al.,
2010) and PfRh5 with basigin (Crosnier et al., 2011). Nothing is known with respect to alterations
that these ligand-receptor interactions mediate on the host cell during these initial stages of merozo-
ite invasion.
Erythrocytes are very flexible and dynamic cells that are able to flow smoothly through the micro-
vasculature and pass swiftly through the spleen. The shear elastic properties of the erythrocyte are
predominantly determined by the underlying spectrin network as well as the connection of integral
membrane proteins with this cytoskeleton. The erythrocyte can undergo repeated large deforma-
tions to facilitate movement through microcapillaries, and these deformations involve the dynamic
remodeling of the spectrin network (Li et al., 2007). Additionally, under normal physiological condi-
tions, calcium (Ca2+) influx or treatment with certain amphipathic drugs can induce membrane bud-
ding (Zuccala et al., 2011; Allan et al., 1976; Ben-Bassat et al., 1972). Also, active ATP-dependent
cytoskeleton forces that are uncorrelated with Brownian noise have been detected in erythrocytes
(Rodrı´guez-Garcı´a et al., 2015). Environmental factors can trigger post-translational modifications
and change the erythrocyte membrane properties, and antibody ligation of CR1 increases erythro-
cyte membrane deformability (Glodek et al., 2010). Phosphorylation and dephosphorylation of
membrane and cytoskeletal proteins is a likely mechanism by which properties of the erythrocyte
membrane are regulated (Mohandas and Gallagher, 2008), and increased phosphorylation of eryth-
rocyte proteins occurs on attachment of P. falciparum merozoites suggesting changes to the host
cell cytoskeleton may be important for parasite entry (Zuccala et al., 2016).
In this study, we show that P. falciparum ligand-receptor interactions affect the deformability of
the erythrocyte. In particular, EBA-175 binding to GPA causes substantial changes in
the deformability of erythrocytes and activates a phosphorylation cascade that alters the viscoelastic
properties of the host membrane, a process that is essential for successful parasite invasion.
Results
Binding of P. falciparum ligands to human erythrocytes affects
deformability
P. falciparum merozoites significantly deform the erythrocyte during invasion and potentially alter
the visco-elastic properties of the host cell (Figure 1A). The effect of P. falciparum ligand-receptor
interactions on the visco-elastic properties of the erythrocyte was determined with recombinant pro-
teins that bind to specific receptors. MSPDBL1, MSPDBL2 (Hodder et al., 2010), EBA-175 region II
(EBA-175 RII), PfRh4 (Tham et al., 2010), PfRh5 (Guz et al., 2014), EBA-140 region II (EBA140 RII)
(Maier et al., 2003) were incubated with human erythrocytes and the Young’s modulus (E) calcu-
lated from the atomic force microscopy (AFM) cantilever deflection as a measure of cell stiffness
(Figure 1B) (Guz et al., 2014). The recombinant proteins MSPDBL1 (Lin et al., 2016,
Figure 1 continued
modulus of neuraminidase treated erythrocytes in the presence or absence of EBA-175 RII. (E) EBA-175 titration on erythrocytes and comparison of the
AFM Young’s modulus (left) with the elongation index measured by rheology (right). 4 mg (B), 3.5 mg (C), 3.8 mg (D) and 1–4 mg (E) were added to 500 mL
erythrocytes in RPMI-HEPES at 2% haematocrit. Error bars represent the mean and SEM for three independent experiments.
DOI: 10.7554/eLife.21083.002
The following figure supplements are available for figure 1:
Figure supplement 1. Binding of P. falciparum recombinant ligands to human erythrocytes.
DOI: 10.7554/eLife.21083.003
Figure supplement 2. Binding of recombinant EBA-140 RII to human erythrocytes.
DOI: 10.7554/eLife.21083.004
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2014), MSPDBL2 (Lin et al., 2016, 2014), PfRh4, PfRh5, EBA-140 RII and EBA-175 RII specifically
bind to erythrocytes. Erythrocyte stiffness was generally reduced by binding of MSPDBL1, MSPDBL2,
PfRh4, PfRh5 and EBA-140 RII (p<0.0001) with EBA-175 RII binding showing a dramatic reduction of
Young’s modulus (Figure 1B; Figure 1—figure supplement 1 and Figure 1—figure supplement 2).
The erythrocyte-binding domain of EBA-175 is region II, a 616 amino acid fragment consisting of
two cysteine-rich Duffy binding-like (DBL) domains (F1 and F2) (Tolia et al., 2005), that binds GPA
(Figure 1C) (Sim et al., 1994; Salinas et al., 2014; Salinas and Tolia, 2014). EBA-175 dimerizes
upon receptor engagement (Tolia et al., 2005), and neutralizing antibodies block the dimer inter-
face and receptor binding residues of EBA-175 RII (Chen et al., 2013). EBA-175 and EBA-140 con-
tain the conserved domain architecture of the EBL family and bind similarly to GPA and GPC
respectively, although the latter binds as a monomer (Malpede and Tolia, 2014; Paing and Tolia,
2014).
As controls we tested the effect of the intrinsically disordered EBA-175 III-V domain (Blanc et al.,
2014), which does not bind erythrocytes (Healer et al., 2013), and it did not significantly influence
erythrocyte deformability (p<0.05, Figure 1C). Erythrocytes incubated with EBA-175 RII together
with anti-EBA-175 RII antibodies, that block binding to GPA and merozoite invasion (Chen et al.,
2013; Healer et al., 2013; Sim et al., 2011), showed no detectable change in host cell stiffness
(p>0.05) consistent with them blocking ligand binding (Figure 1C). EBA-175 and EBA-140 binding
are both dependent on sialic acid moieties on glycophorin receptors (Adams et al., 2001) and thus
sensitive to neuraminidase-treatment of erythrocytes. EBA-175 RII did not affect the stiffness of neur-
aminidase-treated erythrocytes (Figure 1D) indicating a direct link between EBA-175 binding to
GPA and changes in erythrocyte deformability. EBA-175 RII binding showed an expected dose
response on deformability, which was confirmed using ektacytometry (Moyer et al., 2010), consis-
tent with the quantification of EBA-175 RII binding to erythrocytes (Figure 1E; Figure 1—figure sup-
plement 1). Bulk rheology measures of the elongation index showed an increase in erythrocyte
deformability with EBA-175 RII reaching a plateau after 35 nM (Figure 1E), which was close to satu-
ration of GPA binding sites (Poole, 2000). Therefore, binding of EBA-175 RII to glycophorin A on
the erythrocyte surface was responsible for the changes observed in deformability of the host cell.
Binding of EBA-175 to GPA on the erythrocyte increases
phosphorylation of the cytoskeleton
We next determined if the mechanism of EBA-175 RII induced deformability of erythrocytes was a
result of changes in phosphorylation of cytoskeleton components. The EBA-175 RII- treated erythro-
cytes were radiolabeled with 32P inorganic phosphate, and ghosts containing membrane and cyto-
skeleton proteins extracted and analyzed by 2-dimensional (2-D) gel electrophoresis (Figure 2A and
B). An altered intensity of 32P labeling in the EBA-175 RII treated erythrocytes indicated an overall
increase of phosphorylation, and false-color overlays of aligned autoradiographs showed a shift of
particular 2-D spots, revealing some proteins were multiply phosphorylated (Figure 2A and B; Fig-
ure 2—figure supplement 1). Twenty eight of the most prominent 32P-labeled protein spots were
excised from an aligned preparative 2-D gel and analyzed by LC-MS/MS. This identified a subset of
phosphorylated proteins corresponding to erythrocyte membrane skeleton proteins including tropo-
modulin-1, adducin-2, tropomyosin, beta-actin, ankyrin-1, protein 4.1 and cofilin-1. The identity of
these proteins was validated by immuno-blot (Figure 2; Figure 2—figure supplement 1). 2-D image
analysis of 32P autoradiographs and immuno-blots of the same membranes indicated that 32P
labeled 2-D phospho-spots matched accurately with bands for tropomodulin-1 and adducin-2, with
clear changes in their phosphorylation state (Figure 2C–F).
To provide a more quantitative approach we used dimethyl labeling and quantitative liquid chro-
matography-tandem mass spectrometry (LC-MSMS) to enable identification of phosphopeptides at
a global level (Boersema et al., 2010) (Figure 2G–H). EBA-175 RII treated and untreated erythro-
cytes were digested prior to labeling of the lysine and N-terminal residues with either a light or a
heavy dimethyl isotope. Global phosphoproteomics analysis of the phosphopeptide enriched Heavy
(H) + Light (L) mixture revealed a high number (982) of unique phosphopeptides, and the H/L ratio
of unique peptides singly, doubly or triply phosphorylated indicated an overall increase in phosphor-
ylation in the EBA-175 RII treated samples (Figure 2G; Figure 2—figure supplement 2). Quantita-
tive LC-MSMS analysis identified approximately 400 erythrocyte phosphoproteins and revealed a
significant (p<0.05) enrichment of phosphopeptides corresponding to trans-membrane spanning
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Research article Cell Biology Microbiology and Infectious Disease
Figure 2. EBA-175 RII induces an increase in phosphorylation of trans-membrane and cytoskeletal erythrocyte proteins. (A–B) MW vs. pI 2D
electrophoresis gel autoradiographs of EBA-175 RII treated (B) or untreated (A) 32P radio-labeled erythrocyte ghosts. (C–F) Western blot
phosphorylation validation of tropomodulin 1 (C–D) and adducin-2 (E–F). P0-P10 indicate the number of phosphorylation sites. (G) Mass spectrometry
phosphopeptide heavy (H) to light (L) ratios of EBA-175 (H) mixed with PBS (L) treated ghosts. (H). Volcano plot showing quantitative analysis of unique
phosphopeptides. Red dots indicate significant upregulated unique phosphopeptides corresponding to cytoskeletal protein IDs highlighted in the list.
Figure 2 continued on next page
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glycoproteins and cytoskeletal proteins that include GPA and GPC, adducin, ankyrin and dematin,
with many of them multiply phosphorylated (Figure 2H; Figure 2—figure supplement 2;
Supplementary file 1 and 2). Interestingly, both GPA and GPC phosphorylation sites were detected
in the cytosolic domains of these proteins (Figure 2I; Figure 2—figure supplement 2). Therefore
EBA-175 RII binding to erythrocytes induced an overall change in phosphorylation of the cells cyto-
skeletal proteins. These observations suggested an induced modification of the cytoskeleton and
consequent increase deformability upon the specific interaction of merozoite ligands with the host
erythrocyte.
EBA-175 binding to GPA triggers a phosphorylation cascade of
erythrocyte membrane glycoproteins and cytoskeleton proteins by
TRPM7
To identify the kinase(s) involved in erythrocyte phosphorylation triggered by EBA-175 RII binding to
GPA we tested erythrocyte kinase inhibitors that influence erythrocyte deformability. A protein
kinase C (PKC) inhibitor, Go¨9676 (Bailey et al., 2014), four transient receptor potential cation chan-
nel (TRPM7) inhibitors, FTY720, sphingosine (Qin et al., 2013), waixenicin A (Zierler et al., 2011)
and NS8593 (Chubanov et al., 2012), three Rho-kinase inhibitors, Y-27632 (Ruef et al., 2011), sim-
vastatin (Clapp et al., 2013) and HA1077-fasudil (Tiftik et al., 2014), an adenylyl cyclase and protein
kinase A (PKA) stimulator, forskolin (Muravyov and Tikhomirova, 2013), an AMP-activated PK inhib-
itor, dorsomorphin (Liu et al., 2014), a phosphodiesterase inhibitor, isobutyl-methyl-xantine (IBMX,
[Muravyov and Tikhomirova, 2013]), a spleen tyrosine kinase (syk) inhibitor, BAY-3606 (Nor-
man, 2014), a Ca2+ channel inhibitor, verapamil (Ruef et al., 2011) and three inhibitors of mechani-
cally activated currents through channels such as TRPM7 or Piezo1, gadolinium (III), ruthenium red
(Drew et al., 2002) and GsMTx-4 (Dorovkov et al., 2008). Some inhibitors had no effect on overall
growth of P. falciparum whilst others reduced it to less than 50% compared to controls (sphingosine,
Y-27632, IBMX, BAY61-3606, gadolinium (III) and verapamil) (Figure 3A). Strikingly, FTY720, waixeni-
cin A and NS8593, which are TRPM7 inhibitors, blocked parasite growth completely. TRPM7 is a
two-domain protein expressed in most tissues containing both a TRP ion channel and an alpha-
kinase domain (Ryazanova et al., 2004). TRPM7 phosphorylates tropomodulin-1 at the N- terminal
Ser2 and Thr54 residues (Dorovkov et al., 2008), and Ser2 is phosphorylated in erythrocytes
(Weber et al., 1994). These data along with the phosphorylation of tropomodulin-1, induced by
EBA-175 binding to glycophorin A (Figure 2C and D), suggested that TRPM7 may be involved in
this phosphorylation cascade and that TRPM7 inhibitors could block parasite growth by impairing
invasion.
Increased deformability of the host erythrocyte is required for
merozoite invasion
To determine if TRPM7 inhibitors, that blocked P. falciparum growth, directly impaired merozoite
invasion we used the reversible TRPM7 inhibitor FTY720 (Chubanov et al., 2012). Purified mero-
zoites were added to FTY720 or sphingosine treated erythrocytes, and invasion quantified
(Figure 3B). FTY720 inhibited merozoite invasion (IC50 of 34.1 ± 1.1 mM) whereas sphingosine had
no effect. Additionally, we performed growth inhibition assays to confirm the activity of FTY720. Syn-
chronized 3D7 trophozoites were treated with different concentrations of each compound and the
parasitemia determined to obtain an inhibitory dose response. FTY720 (IC50107.3 ± 1.0 mM) showed
Figure 2 continued
(I) Amino acid sequence of glycophorin A (top), red square highlights the cytoplasmic domain conserved across different species. Glycophorin A unique
phosphopeptides detected (bottom), red circles point out phosphorylation sites all located in the cytoplasmic domain.
DOI: 10.7554/eLife.21083.005
The following figure supplements are available for figure 2:
Figure supplement 1. Binding of EBA-175 tohuman erythrocytes activates increased phosphorylation of the host cytoskeleton.
DOI: 10.7554/eLife.21083.006
Figure supplement 2. Quantitation and identification of peptides phosphorylated after EBA-175 binding to human erthrocytes.
DOI: 10.7554/eLife.21083.007
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Figure 3. FTY720 and Waixenicin A, inhibitors of TRPM7, block P. falciparum erythrocyte invasion. (A) Parasitemia after 12–16 hr post addition of
synchronous schizonts to erythrocytes treated with different inhibitors at 50 mM. Parasitaemia was normalized to the control. Error bars show SEM
corresponding to three independent experiments. (B) Invasion inhibition assays. Purified merozoites from either 3D7 (left) or 3D7DEBA-175 (right)
parasite lines were added to erythrocytes treated with varied concentrations of FTY720 or sphingosine. Parasitaemia was counted after 24 hr,
Figure 3 continued on next page
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potent inhibition (Figure 3C) whilst HA1077 and sphingosine showed little to none. To further test
whether FTY720 was inhibiting invasion rather than interfering with parasite development we tested
the inhibitory activity of waixenicin A (Figure 3D). This compound is a slow acting inhibitor of
TRPM7 and therefore could be incubated with erythrocytes and washed out before testing merozo-
ite invasion (Zierler et al., 2011). When waixenicin A-treated erythrocytes were tested a similar
result was obtained for either washed (IC50 59.4 ± 1.2 mM) or unwashed (IC5058.8 ± 1.1 mM) host cells
(Figure 3D). Therefore, FTY720 and waixenicin A block invasion of P. falciparum merozoites by inhib-
iting an essential erythrocyte function(s).
Interestingly, the same results were observed for 3D7DEBA-175 parasites that lack expression of
EBA-175, where FTY720 inhibited merozoite invasion (IC50 20.8 ± 1.2) (Figure 3B) and parasite
growth (IC5095.2 ± 1.0 mM) (Figure 3C). Similarly, waixenicin A also inhibited 3D7DEBA-175 growth
(IC50 43.8 ± 1.3 mM) (Figure 3D). The ability of FTY720 and waixenicin A to inhibit invasion of EBA-
175 deficient parasites were consistent with this ligand not being essential for merozoite invasion as
other members of the EBA and PfRh family of proteins have overlapping functions
(Duraisingh et al., 2003; Stubbs et al., 2005; Lopaticki et al., 2011). EBA-175 function is redundant
but the overall function of the EBA and PfRh families is essential (Lopaticki et al., 2011). Whilst
EBA-175 RII binding had a significant effect on erythrocyte deformability other ligands such as EBA-
140 RII, which binds to GPC (Maier et al., 2003), and PfRh4, which binds to CR1 (Tham et al.,
2010), also had an effect although not to the same magnitude as EBA-175 RII (Figure 1B). GPA is
the most abundant integral protein on the erythrocyte surface, present at 106 copies per cell
(Poole, 2000). In contrast, there are approximately 225,000 molecules of GPC per erythrocyte
(Smythe et al., 1994), and the normal level of CR1 in Europeans is between 50–1200 molecules per
cell (Wilson et al., 1986). The higher abundance of GPA explains the lesser effect of EBA-140 RII
and PfRh4 on the deformability of treated erythrocytes. Therefore, it is likely that in the absence of
EBA-175 expression other members of the EBA and PfRh protein families perform an identical func-
tion that alters the deformability of the erythrocyte through the TRPM7 pathway, and this is essential
for merozoite invasion.
Binding of EBA-175 to GPA on erythrocytes altered their deformability and, in addition, induced
phosphorylation of host trans-membrane spanning glycoproteins and cytoskeletal proteins. Inhibitors
of TRPM7, a divalent cation channel with a kinase domain, blocked merozoite invasion. The hypothe-
sis that TRPM7 blocked invasion by interfering with the phosphorylation cascade induced by EBA-
175 RII was tested by performing a global phosphoproteomic analysis. Erythrocytes were treated
with EBA-175 RII in the absence or presence of FTY720, labeled at protein primary amine residues
with a heavy (H) or an intermediate (M) dimethyl isotope respectively, and mixed with light (L)
dimethyl labeled untreated erythrocytes (1:1:1). Average H/L ratios of unique peptides singly, doubly
or triply phosphorylated of EBA-175 RII-treated erythrocytes were higher than average M/L ratios in
EBA-175 RII/FTY720 host cells, indicating that FTY720 inhibited the phosphorylation cascade acti-
vated by EBA-175 RII binding to GPA (Figure 4A). Importantly, quantitative analysis of confidently
identified phosphoproteins (peptide FDR < 1%) revealed a significant downregulation of phosphory-
lation of host cytoskeletal proteins when treated with EBA-175 RII in the presence of FTY720
(p<0.05), in particular GPA (Figure 4B). Therefore, FTY720, a TRPM7 inhibitor, blocked phosphoryla-
tion of erythrocyte proteins induced by EBA-175 RII binding to GPA. Consequently, FTY720 inhibits
merozoite invasion by blocking the phosphorylation cascade activated by EBA-175 RII binding to
GPA in the erythrocyte.
Physiological shear stress in the circulation causes a reversible increase in erythrocyte Ca2+ per-
meability (Larsen et al., 1981). In a similar manner, the EBA-175 RII induced increase in deformabil-
ity could increase erythrocyte calcium permeability. A high content fluorescence imaging method
was established and used to test Ca2+ uptake into Fluo-4-AM (a Ca2+ indicator) loaded erythrocytes
Figure 3 continued
normalized to the control and expressed as % inhibition. (C) Growth inhibition assays (GIAs) showing inhibitory activity of FTY720, HA1077 and
sphingosine for 3D7 (left) and 3D7DEBA-175 (right) parasite lines. (D) GIAs after washing or not washing waixenicin A treated 3D7 (left) and 3D7DEBA-
175 parasites (right). All trophozoite-synchronized cultures were treated with serial inhibitor concentrations and parasitaemia was counted after 24 hr.
Error bars show SEM corresponding to three independent experiments.
DOI: 10.7554/eLife.21083.008
Sisquella et al. eLife 2017;6:e21083. DOI: 10.7554/eLife.21083 8 of 20
Research article Cell Biology Microbiology and Infectious Disease
Figure 4. FTY720 inhibits P. falciparum invasion by interfering with a post-translational pathway triggered by EBA-175 binding to GPA. (A)
Phosphopeptide heavy (H) to light (L) ratios of EBA-175 (H) with PBS (L) treated ghosts (left). Phosphopeptide intermediate (M) to light (L) ratios of EBA-
175 and FTY720 treated (M) with untreated (L) ghosts (right). (B) Equivalent quantitative analysis of unique phosphopeptides represented in volcano
plots showing that GPA phosphorylation sites are not phosphorylated in the presence of FTY720. (C) Fluorescence microscopy showing of erythrocytes
Figure 4 continued on next page
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incubated with EBA-175 RII (Figure 4C). Imaging showed an increment in the number of fluorescent
cells when incubated with EBA-175 RII suggesting either a decrease in the integrity of the cell mem-
brane due to increased deformability or a directly induced Ca2+ uptake (Figure 4D). Additionally,
inclusion of FTY720 with EBA-175 RII decreased the number of fluorescent cells detected (p<0.03)
whereas HA1077 and sphingosine did not show a significant effect (p>0.05). Furthermore, FTY720
and waixenicin A inhibited the increased deformability caused by binding of EBA-175 RII to GPA as
measured by AFM (p<0.0001) (Figure 4E), confirming the causal connection between deformability
and the changes in phosphorylation upon EBA-175 RII binding. AFM also showed that FTY720 inhib-
ited the changes in erythrocyte stiffness caused by binding of EBA-140 RII and PfRh4 (p<0.001)
(Figure 4E) consistent with invasion ligands other than EBA-175 RII having the same effect on the
TRPM7 dependent phosphorylation pathway.
To determine if FTY720 decreased the ability of merozoites to deform the erythrocyte during
invasion, schizonts were purified and added to erythrocytes stained with Bodipy TR Ceramide, a via-
ble membrane dye that allows invasion (Volz et al., 2016). Live imaging of merozoites in the process
of interaction with an erythrocyte showed that, in the presence of FTY720, the parasite was able to
contact and attach, but could not invade (Figure 4F and G, Videos 1 and 2). Furthermore, they
were only able to weakly deform the erythrocytes with deformation scores (Weiss et al., 2015) of 0–
1, as compared to merozoites in the absence of inhibitor, which were able to dramatically deform
the host cell (Figure 4G and H). Overall, merozoites in the presence of FTY720 were able to contact
and attach to erythrocytes as well as untreated parasites but showed either weak or no deformation
of the cell they attempted to invade (Figure 4H). The decrease or lack of deformation by treated
parasites confirmed that FTY720 blocked merozoite invasion by decreasing the deformability of the
erythrocyte as a result of inhibition of the phosphorylation cascade induced by interaction of parasite
ligands with host receptors.
Discussion
Our results showed that interaction of P. falcipa-
rum merozoites with the outside of the erythro-
cyte activates a phosphorylation cascade
Figure 4 continued
in the presence of calcium indicator Fluo-4-AM. EBA-175 treated erythrocytes (bottom) are more permeable to Ca2+. Scale bar 40 mm. (D) High content
screen analysis of the number of Fluo-4-AM bright cells untreated or treated with EBA-175 RIII-IV and EBA-175 RII in the presence of FTY720, HA1077
and sphingosine (50 mM). (E) AFM Young’s modulus measurements. Erythrocytes treated with PBS or EBA-175 RII in the presence of FTY720 or
waixenicin A (left). Erythrocytes treated with EBA-140 RII (middle) or PfRh4 (right) in the absence or presence of FTY720. (F) Frames of live imaging
experiments for 3D7 merozoites and erythrocytes in the absence or presence of FTY720 (6 mM). In each condition, bright field is shown in top panels
and 594 channels in the bottom ones. Scale bars are 5 mm. (G) Table detailing the number of merozoites (Mero) that attach, contact (number of
contacted erythrocytes), deform, invade and undergo echinocytosis (Echinocyt). (H) Stacked graphs showing the deformation score percentage of total
interactions for 3D7 merozoites in the absence or presence of FTY720. Deformation scores are according to a simplified four-point deformation scale
(Weiss et al., 2015). Error bars show SEM corresponding to three independent experiments.
DOI: 10.7554/eLife.21083.009
Video 1. This video is linked to Figure 4F which shows
the still time lapse images of this video-microscopy of
P. falciparum merozoites invading Bodipy TR Ceramide
labelled human erythrocytes. This shows the
deformation caused by the merozoites during the initial
interaction before invasion is activated.
DOI: 10.7554/eLife.21083.010
Video 2. This video is linked to Figure 4F which shows
the still time lapse images of this video-microscopy of
P. falciparum merozoites attempting to invade Bodipy
TR Ceramide labelled human erythrocytes in the
presence of FTY720. This shows the lack of severe
deformation caused by the merozoites during the initial
interaction and their inability to invade. This is linked to
Figure 4F which shows the still time lapse images of
the movie.
DOI: 10.7554/eLife.21083.011
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resulting in increased deformability and that this activation is essential for successful invasion. Whilst
we have used soluble EBA-175 RII to bind to GPA over the surface of the erythrocyte the merozoite
only interacts with a small portion of the surface, and it is likely that the increased deformability is
more local and that the interaction of the EBA and PfRh protein families conditions this area so that
the parasite can more easily deform the host cell, a step that is required for subsequent tight junc-
tion formation and entry (Weiss et al., 2015). Whilst this step appears to be essential EBA-175 func-
tion is generally redundant (Duraisingh et al., 2003; Lopaticki et al., 2011) but the fact that FTY720
and waixenicin A block invasion in the absence of this ligand suggests phosphorylation is a required
step in invasion. The ability of other members of the EBA and PfRh family of proteins to render the
erythrocyte more deformable suggests they are capable of performing this function to condition
areas of the host cell as well as signaling downstream events in the invasion pathway (Tham et al.,
2015).
Interaction of EBA-175 with the erythrocyte surface compromises the mechanical stability of the
membrane and its skeleton. Many constituent proteins of the erythrocyte membrane skeleton can
be phosphorylated by various kinases, and phosphorylation of b-spectrin by casein kinase and pro-
tein 4.1R by PKC has been documented to modulate the erythrocyte membrane mechanical stability
(Manno et al., 2005). A recent study showed that activation of endogenous PKA by cAMP decreases
membrane mechanical stability and that this effect is mediated primarily by phosphorylation of
dematin (Koshino et al., 2012). Our data show that EBA-175 binding to GPA triggers the phosphor-
ylation of trans-membrane spanning and cytoskeletal proteins, including GPA, a mechanism that
weakens the erythrocyte membrane and increases cytosolic calcium concentration, as a result of per-
meability rather than receptor mediated store release as erythrocytes lack intracellular stores
(Cahalan et al., 2015). FTY720, a transient receptor potential cation channel (TRPM7) inhibitor,
reduces quantitatively the level of phosphorylation on the erythrocyte membrane and cytoskeleton,
induced by EBA-175. TRPM7 plays a key role in the regulation of calcium and magnesium homeosta-
sis (Langeslag et al., 2007), and although the function of TRPM7 kinase domain (Ryazanova et al.,
2004) in human cells is still unclear, it autophosphorylates, autoregulates and it can also phosphory-
late other proteins such as tropomodulin-1, b-actin (Dorovkov et al., 2008), annexin I
(Dorovkov and Ryazanov, 2004) and myosin IIA (Clark et al., 2006). FTY720 has been shown to
suppress TRPM7-dependent motility of HEK293 cells (Chokshi et al., 2012) and to abrogate erythro-
cyte rigidity in trauma/haemorrhagic shock (Bonitz et al., 2014).
This study shows that inhibitors of TRPM7 block parasite invasion by interfering with host phos-
phorylation mechanisms making the area around which the merozoite is interacting less deformable.
Therefore the initial interaction of parasite ligands with erythrocyte receptors activates host cell
changes that are essential for successful invasion and infection.
Materials and methods
Reagents
3D7 is a cloned line derived from NF54, supplied by David Walliker, Edinburgh University. Disruption
of EBA-175 was previously published (Lopaticki et al., 2011). Purified recombinant EBA-175 RII anti-
gen was kindly provided by Science Applications International Corporation (SAIC). Sequence encod-
ing EBA-175 RIII-V was codon-optimized for expression in E. coli and synthesized by Genscript.
Antibodies against EBA-175 RII were obtained as described before (Healer et al., 2013). Recombi-
nant PfRh4 containing the full erythrocyte-binding domain (Rh4.9) was obtained as described
(Tham et al., 2009). MSPDBL1 and MSPDBL2 was expressed recombinantly in E. coli as previously
described (Lin et al., 2014). EBA-140 RII was expressed and purified as described previously
(Malpede et al., 2013; Lin et al., 2012). Briefly, EBA-140 RII was expressed in E. coli and recovered
from inclusion bodies. The denatured protein (100 mg/L) was refolded by rapid dilution for 48 hr at
4˚C in 50 mM Tris (pH 8.0), 10 mM EDTA, 200 mM arginine, 0.1 mm PMSF, 2 mM reduced glutathi-
one and 0.2 mM oxidized glutathione. After refolding, EBA-140 RII was purified by ion-exchange
and size exclusion chromatography into the final buffer of 10 mM HEPES pH 7.4 150 mM NaCl.
Kinase inhibitors were obtained commercially. FTY720, NS8593, Y-27632, simvastatin, HA1077-fasu-
dil, forskolin, dorsomorphin, IBMX, BAY-3606, verapamil and gadolinium (III) from Sigma.
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Sphingosine, ruthenium red and GsMTx-4 from Abcam and Go¨9676 from Cell Signalling. Waixenicin
A was extracted and purified from soft coral tissue as described previously (Zierler et al., 2011).
Erythrocyte binding assays
The erythrocyte binding assays prior to AFM indentation and rheology were performed as follows.
10 mL washed packed blood (Australian Red Cross) was mixed with different amounts of protein (1–4
mg), resuspended in 500 mL RPMI-HEPES (2% haematocrit) and incubated at room temperature for 1
hr. For controls and inhibitor tests, antibodies (10 mg/mL) and inhibitors (50 mM) were added
together with EBA-175 RII. Waixenicin A was incubated and washed prior to adding EBA-175 RII.
Erythrocyte binding assays to generate binding curves using EBA175 RII, Rh4.9 and Rh5 were per-
formed as above. Erythrocytes and proteins were centrifuged for 30 s at 13000 rpm through 400 ml
dibutyl phthalate (Sigma) to remove unbound protein. After aspiration of dibutyl phthalate and
buffer, 10 ml 1.6 M NaCl solution was added to the erythrocyte pellet to elute bound protein. Sam-
ples were vortexed for 5 s at 3 min intervals over 10 min to ensure equal mixing of 1.6 M NaCl solu-
tion. Samples were spun at 13000 rpm, 4 min and the supernatant, containing eluted protein, was
suspended in 2X SDS sample buffer. In all binding assays, a buffer control was included containing
RMPI wash buffer + amount of protein suspension buffer equivalent to the highest concentration of
protein used. In one repeat experiment binding was performed in PBS instead of RMPI wash buffer.
Western blotting
Samples were denatured in 2X SDS reducing sample buffer and loaded on 4–12% or 10% Bis-Tris or
3–8% Tris-Acetate gels (Invitrogen). Gels were run at 150V in MOPS or Tris-Acetate for one hour,
and electrophoresed proteins were transferred to nitrocellulose membrane (Protran, Whatman) via
wet transfer protocol. Blocking solution used was skim milk solution or Odyssey blocking buffer
(LiCor). Protein bands after incubation with HRP-conjugated secondary antibody were detected by
ECL detection reagent (GE Healthcare) and exposure to X-ray film (FUJIFILM). In the case of fluores-
cent WB, visualisation and quantitation was carried out with the LiCor Odyssey scanner (800 nm and
700 nm wavelength channels) and Odyssey software.
Densitometry quantitation
Fluorescently probed membranes were scanned and analysed by LiCor Odyssey imaging software.
An extra-sum-of-squares F test was used to compare the linear regression of the Log (protein levels)
and Log (adhesin amount) to a line where y-intercept and slope = 0.
Flow cytometry quantitation
Erythrocyte binding assay was adapted from Salinas et al. (2014) (Tolia et al., 2005). Briefly, 1 uM
RII-140-6xhis, purified identically as untagged RII-140, was added to the RBCs for 1 hr at room tem-
perature and then washed three times with DMEM 10% FCS. Anti-his antibody conjugated to FITC
was then incubated with the samples for 1 hr at room temperature and then washed three times
with DMEM 10% FCS. Finally, RBCs were diluted to 2 mL in DMEM 10% FCS. Samples, in triplicate,
were run using a BD FACSCanto machine to collect 30,000 counts each and analyzed with FlowJo
software.
Neuraminidase treatment of erythrocytes
50 mL washed packed blood (Australian Red Cross) was mixed with 10 mL Neuraminidase from Vibrio
cholerae (Sigma), 90 mL RPMI-Hepes/NaHCO3 and incubated in a waterbath at 37˚C for 1 hr. Treated
cells were spun down and washed five times with RPMI-Hepes/NaHCO3 before incubation for bind-
ing assays and AFM measurements.
Atomic force microscopy indentation of erythrocytes
Erythrocyte solutions were deposited onto freshly cleaved mica and an MFP3D-BIO instrument (Asy-
lum Research) used. Samples were nanoindented under RPMI-HEPES with MLCT silicon nitride
probes (nominal spring constant 0.1 N/m, resonant frequency 38 kHz, Bruker AFM Probes). To calcu-
late erythrocyte modulus a total of 1000 force curves were registered distributed in at least 20 differ-
ent points for each condition. Analysis was made by NanomechPro software (Asylum Research).
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Rheology measurements
Samples were centrifuged at 6000 rpm for 1 min and the 10 mL blood pellet resuspended in 600 mL
polyvinylpyrrolidone (PVP) solution at 25 mPa second viscosity (Rheo Meditech). Elongation index
(EI) over 1–20 Pa shear stress was measured three times for each sample in a RheoScan rheometer
according to manufacturer’s instructions (RheoMeditech, Seoul, Korea). EI at low shear stress (3 Pa)
was plotted for every concentration of EBA-175 RII. At low shear stress rheology presents the high-
est sensitivity to RBC membrane properties, and erythrocytes exhibit maximal deformability
(Musielak, 2009).
Ghost preparation and radiolabeling
Erythrocytes were washed and resuspended (50% haematocrit) with calcium-free Krebs-Ringer buffer
(Sigma). 125 mL of cell suspension was incubated for 2 hr with 125 mCi of 32P (Perkin Elmer) and
either 18 mg of EBA-175 RII or the equivalent volume of Krebs-Ringer buffer. Suspensions were spun
down at 3000 g for 4 min at room temperature and the supernatant was discarded. Erythrocyte pel-
lets were lysed with ice cold 5 mM sodium phosphate pH eight buffer with protease (cOmplete,
Sigma) and phosphatase (Halt, Thermo Fisher) inhibitors, spun down at 100000 g and washed three
times with the same buffer. The resulting ghost pellets were snap-frozen in liquid Nitrogen and
stored at  80˚C until further use.
2D gel electrophoresis
Ghost pellets were subjected to a series of freezing/thawing cycles to remove remaining haemoglo-
bin and resuspended in 300 mL of 2-DE sample buffer (7 M Urea, 2M Thiourea, 4% CHAPS, 50 mM
DTT, 1% ampholytes), loaded onto 13 cm pI 4–7 IPG strips by passive rehydration and focused at a
current limit of 50 mA/IPG strip using a fast voltage gradient (8000 V max, 24,000 Vh) at 15˚C. The
second dimension was carried out on pre-cast 4–12% Bis-Tris Midi Protein Gels using a NuPAGE
Novex system (Life Technologies) at 75 V constant voltage and 10˚C. Analytical 2-D gels were trans-
ferred to PVDF membranes using an iBlot Dry Blotting System (Life Technologies) and imaged using
BAS-IP SR 2040 E phosphor storage plates (GE Healthcare) for 48 hr. High-resolution imaging and
accurate quantitation of 32P-labeled protein spots was achieved using a Typhoon FLA 7000 laser-
scanning detection system (GE Healthcare). Preparative 2-DE gels were stained using Colloidal Coo-
massie Brilliant Blue (Sigma) and spots matching 32P-labeled protein spots manually excised and sub-
jected to LC-MS/MS analysis.
Gel excision, in-gel digestion and nano-LC-MS/MS
Protein spots were manually excised from preparative 2-D gels and subjected to manual in-gel
reduction, alkylation and tryptic digestion. All gel samples were reduced with 10 mM DTT (Sigma)
for 30 min, alkylated for 30 min with 50 mM iodoacetamide (Sigma) and digested with 375 ng trypsin
gold (Promega) for 16 hr at 37˚C. The extracted peptide solutions were then acidified (0.1% formic
acid) and concentrated to 10 mL by centrifugal lyophilisation using a SpeedVac AES 1010 (Savant).
Extracted peptides were injected and fractionated by reversed-phase liquid chromatography on a
nanoACQUITY UHPLC system (Waters, USA) using a nanoACQUITY C18 150 mm  0.15 mm I.D.
column (Waters, USA) developed with a linear 60 min gradient with a flow rate of 250 nL/min from
100% solvent A (0.1% formic acid in Milli-Q water) to 60% solvent B (0.1% formic acid, 60% acetoni-
trile (Thermo Fisher, USA), 40% Milli-Q water). The nano-UHPLC was coupled on-line to a Q-Exactive
Orbitrap mass spectrometer equipped with a Proxeon nano-electron spray ionization source
(Thermo Fisher, USA) for automated MS/MS. High mass-accuracy MS data was obtained in a data-
dependent acquisition mode with the Orbitrap resolution set at 75,000 and the top-ten multiply
charged species selected for fragmentation by HCD (single and doubly charged species were
ignored). The ion threshold was set to 15,000 counts for MS/MS. The CE voltage was set to 27.
Mass spectra database searching
For protein identification of protein spots LC-MS/MS data were searched against a non-redundant
protein decoy database comprising sequences from P. falciparum, as well as their reverse sequences
and common contaminants. Mass spectra peak lists were extracted using extract-msn as part of Bio-
works 3.3.1 (Thermo Fisher Scientific) linked into Mascot Daemon (Matrix Science, UK). Peak lists for
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each nano-LC-MS/MS run were searched using MASCOT v2.2.04 (Matrix Science, UK), provided by
the Australian Proteomics Computational Facility (www.apcf.edu.au). The search parameters con-
sisted of carbamidomethylation of cysteine as a fixed modification (+57 Da), with variable modifica-
tions set for NH2-terminal acetylation (+42 Da) and oxidation of methionine (+16 Da). A precursor
mass tolerance of 20 ppm, fragment ion mass tolerance of ±0.04 Da and an allowance for up to
three missed cleavages for tryptic searches was used. Scaffold v4.4.3 (Proteome Software, Inc., USA)
was used to validate protein identifications derived from MS/MS sequencing results (FDR <0.5%).
Mass spectrometry sample preparation
For global phosphoproteomics analyses, ~200 mG of frozen ghost pellets were extracted in 200 mL
lysis buffer (1% SDS, 2 x Complete Protease Inhibitor Cocktail-EDTA (Roche), in 10 mM HEPES pH
8.5), reduced with 20 mM TCEP (Sigma) for 15 min, alkylated for 30 min with 50 mM iodoacetamide
(Sigma) and digested with 4 mG trypsin gold (Promega) for 16 hr at 37˚C, using the SP3 on-bead
digestion method (Hughes et al., 2014). The extracted peptide solutions were then desalted using
C18 MacroSpin columns and on-column stable isotope dimethyl labeling of differentially treated
samples was performed using light (12CH2O), medium (
12CD2O) or heavy (
13CD2O) formaldehyde
(Sigma), as previously described (Boersema et al., 2009). Differentially labelled peptide samples
were then mixed 1:1 and phosphopeptide enrichment was achieved using sequential elution from
IMAC or TiO2 columns, as detailed elsewhere (Thingholm et al., 2008).
Quantitative proteomics analysis
Relative quantitation of differentially labeled RBC phosphopeptide preparations was performed
using the MaxQuant software package (Cox and Mann, 2008). High-resolution MS data were
searched using a tolerance of 10 ppm for precursor ions and 20 mmu for productions. Enzyme speci-
ficity was tryptic and allowed for up to two missed cleavages per peptide. Carbamidomethylation of
cysteines (+57) was specified as a constant modification with oxidation of methionine (+16), protein
N-terminal acetylation (+52) and light (L; 4 = +28), intermediate (M; 4 = +32) or heavy (H;
4 = +36) dimethyl labels on the peptide N termini and lysine residues set as variable modifications.
The MS data were searched against human, bovine, or P. falciparum proteins in the non-redundant
MSPnr protein database at a 1% false discovery rate (FDR). A robust permutation test was used to
analyze MaxQuant data and evaluate statistically significant differences in the relative abundance of
RBC phosphopeptides (Nguyen et al., 2012).
Inhibitor screen
Highly synchronous mature schizonts (from a 30 mL culture of >5% parasitemia) were magnet puri-
fied (MACS; Miltenyi Biotec) and plated in triplicates (50 mL) at 1% parasitemia and 1% haematocrit.
Parasites were allowed to egress and reinvade fresh erythrocytes for a period of 12–16 hr at 37˚C in
the presence of inhibitors (50 mM) or equivalent volumes of buffer (water, DMSO or KR buffer). Para-
sitemia was determined by GIEMSA staining.
Merozoite invasion inhibition assays
Merozoites were purified based on an established method (Boyle et al., 2010). Highly synchronous
mature schizonts were isolated from uninfected erythrocytes with a MACS magnet separation col-
umn (Miltenyi Biotec). Purified schizonts were incubated with 10 mM of the cysteine protease inhibi-
tor E64 to prevent schizont ruptures. After 5–6 hr of incubation, schizont pellets were passed
through a 1.2 mm syringe filter (Acrodisc; 32 mm; Pall). Filtrate containing purified merozoites was
immediately added to fresh erythrocytes (70–80% hematocrit). The mix was transferred to a 96 well
round bottom microtitre plates (Falcon) in 50 mL aliquots with doubling dilutions of each inhibitor (5–
250 mM) or control buffer and incubated in a shaker at 37˚C. After incubation for 24 hr each well was
fixed at RT for 30 min with 50 mL of 0.25% glutaraldehyde (ProSciTech) diluted in PBS. Following
centrifugation at 1200 rpm for 2 min, the supernatants were discarded and trophozoite stage para-
sites were stained with 50 mL of 5X SYBR Green (Invitrogen) diluted in PBS. The parasitemia of each
well was determined by counting 50,000 cells by flow cytometry using a Cell Lab Quanta SC – MPL
Flow Cytometer (Beckman Coulter). Invasion rate was calculated as %-invaded relative to untreated
controls. All samples were tested in triplicate.
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Growth inhibition assays.
A Growth Inhibition Assay (GIA) protocol was modified from a previously described method
(Persson et al., 2006). Trophozoite stage parasites at 0.5% parasitemia were grown in a 50 mL cul-
ture at 2% hematocrit in 96 well round bottom microtitre plates (Falcon) with doubling dilutions of
each each inhibitor (5–250 mM) or control buffer. After incubation for 48 hr each well was fixed at RT
for 30 min with 50 mL of 0.25% glutaraldehyde (ProSciTech) diluted in PBS. Following centrifugation
at 1200 rpm for 2 min, the supernatants were discarded and trophozoite stage parasites were
stained with 50 mL of 5X SYBR Green (Invitrogen) diluted in PBS. The parasitemia of each well was
determined by counting 50,000 cells by flow cytometry using a Cell Lab Quanta SC – MPL Flow
Cytometer (Beckman Coulter). Growth was expressed as a percentage of the parasitemia obtained
using an inhibitor-free control. All samples were tested in triplicate.
High content fluorescence screen
Erythrocyte binding assays in this case were performed as follows. Erythrocytes (Australian Red
Cross) were previously incubated with Fluo-4 AM (Life Technologies), 1:250 dilution to 1% haema-
tocrit erythrocytes in RPMI-HEPES and washed. 2.5 mL packed RBCs were mixed with EBA-175 RII or
RIII-V (2 mg), resuspended in 50 mL RPMI-HEPES (5% haematocrit) and incubated at RT for 1 hr.
FTY720 and sphingosine were added together with EBA-175 RII at a 50 mM concentration. After
incubation samples were diluted with RPMI-HEPES to 0.05% haematocrit and transferred to 100 mL
aliquots into BD Falcon 384 well TC-treated plates. Plates were read in an Opera Phenix high con-
tent screening system for brightfield, phase contrast and 488 nm fluorescence. These experiments
were repeated three independent times and standard error of the mean calculated.
Live imaging of merozoite invasion
Fresh erythrocytes (1% hematocrit) were washed in complete RPMI-Hepes culture medium. Bodipy
TR Ceramide (Thermo Fisher Scientific) was added at 1:1000 dilution and incubated for >1 hr. Eryth-
rocytes were washed 2–3 times with complete RPMI-Hepes and then resuspended in 2 mL of com-
plete RPMI-Hepes. Highly synchronous schizonts (>5% parasitemia from a ~3% hematocrit 30 mL
culture) were magnet purified, then added to the labelled erythrocytes (0.1% haematocrit) and 2 mL
of this transferred to a 35 mm Fluorodish (World Precision Instruments). Live imaging was performed
at 37˚C on a Leica SP8 confocal microscope. A 63x/1.4 NA Oil Immersion objective on the Leica SP8
confocal. Time-lapsed images were collected every second upon schizont rupture (594 filter) with an
8 kHz resonant scanner with 4x line averaging and HyD detectors. Cells were maintained at 37˚C in a
low O2 and CO2 nitrogen atmosphere. ImageJ Fiji was used to assemble image series and perform
image analyses. Deformation scores were determined according to an established method
(Weiss et al., 2015).
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